Pre-Conference Workshop | ESCV 2022 - 24th Annual Conference of the European Society for Clinical Virology

Pre-Conference Workshop:

Out of a Pandemic: Lessons Learned for Better Future Viral Diagnostics

This will be a one-day workshop designed to consider the lessons learned from COVID-19 pandemic to improve infectious disease diagnostics.

Date: Tuesday, September 06, 2022

Time: 10:00 – 17:00

Hall: TBA

Registration: To register for the workshop, please proceed to the online registration system. You can complete your workshop registration together with your conference registration process.

The key messages are:

1) The relevance of the specific measurands in clinical management of infectious disease
2) The availability of reference materials at concentrations that support clinical decision-making /public health management
3) The challenges to Harmonise measurement for complex markers like serology
4) The opportunities and challenges for “Agnostic Assays” such as NGS and Mass Spec

Preliminary Pre-Conference Workshop
SEPTEMBER 6, 2022 - TUESDAY
Time	Sessions
10:00 - 10:15	Welcome and opening of the workshop Neil Almond
10:15- 12:00	Session I: Molecular Diagnostics
	*Chair: Paul Klapper* Invited speakers (TBC) followed by a discussion session which will cover the following: What are the challenges for establishing new molecular assays? Which comes first new assays or a clinical need to measure virus? What are the relative value of time to result, sensitivity, accuracy?
12:00 - 13:00	Lunch break
13:00 - 14:30	Session II: Serology
	*Chair: Heli Harvala* Invited speakers (TBC) followed by a discussion with the following points: Relating antibodies measured in assays with those that are clinically relevant? Specificity and quantity – which is more relevant? What are the risks and benefits from having multiple serology platforms in a lab?
14:30 - 15:00	Coffee break
15:00 - 17:00	Session III: Agnostic Diagnostics
	*Chair: Peter Coyle* Invited speakers (TBC) and lively discussion focusing on: When do we need Agnostic assays to be used? Local Hospital or Regional Referral Labs? Is quantitative or qualitative info needed from these assays? How can the quality of assays be assured? Where should the Bioinformatic expertise be located? The final speaker (TBC) in this session will focus on future – how can we optimise diagnostic platforms and what do we need to consider with the IVDR.